Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary M. Heckler
ERK/MAPK Regulates ERRγ Expression, Transcriptional Activity and Receptor-Mediated Tamoxifen Resistance in ER+ Breast Cancer
FEBS Journal
Biochemistry
Cell Biology
Molecular Biology
Related publications
Estrogen Receptor (ER ) Level but Not Its ER Cx Variant Helps to Predict Tamoxifen Resistance in Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Estrogen Receptor Regulates E2F1 Expression to Mediate Tamoxifen Resistance
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
AKT1 - A New Marker for Tamoxifen Resistance in ER-Dependent Breast Cancer
MicroRNA-221/222 Negatively Regulates Estrogen Receptor Α and Is Associated With Tamoxifen Resistance in Breast Cancer.
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
PLoS ONE
Multidisciplinary
SpliceArray Profiling of Breast Cancer Reveals a Novel Variant of NCOR2/SMRT That Is Associated With Tamoxifen Resistance and Control of ER Transcriptional Activity
Cancer Research
Cancer Research
Oncology
IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
PLoS ONE
Multidisciplinary
Nogo-B Receptor Increases the Resistance to Tamoxifen in Estrogen Receptor-Positive Breast Cancer Cells
Breast Cancer Research
Cancer Research
Oncology
